Carregant...

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma.

The present study was designed in order to evaluate the response rate and the toxicity of continuous infusion of Interleukin 2 (IL2) in patients over 65 with metastatic renal cell carcinoma. Twenty-five patients, median age 69 (range 65-77), without any prior systemic anticancer therapy received a c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Négrier, S., Mercatello, A., Bret, M., Thiesse, P., Blay, J. Y., Coronel, B., Merrouche, Y., Oskam, R., Franks, C. R., Clavel, M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1992
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977403/
https://ncbi.nlm.nih.gov/pubmed/1586600
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!